Bill Text: IL SR1369 | 2017-2018 | 100th General Assembly | Introduced

---

Bill Title: Designates the month of October 2018 as Eczema Awareness Month.

Spectrum: Partisan Bill (Democrat 1-0)

Status: (Passed) 2018-05-22 - Resolution Adopted [SR1369 Detail]

Download: Illinois-2017-SR1369-Introduced.html

---

SR1369 LRB100 19627 ALS 34900 r
SENATE RESOLUTION
WHEREAS, Eczema is a set of skin conditions that cause red,
itchy, and inflamed skin, and has profound medical,
psychosocial, and economic effects on patients, families, and
their communities; and
WHEREAS, The prevalence of eczema in the United States is
10.1 percent; and
WHEREAS, Eczema affects over 31.6 million children and
adults in the United States alone; and
WHEREAS, Eczema's medical effects include dry, cracked,
and scaly skin, incessant itch, chronic pain, and sleep
deprivation; and
WHEREAS, 41.5 percent of adult eczema patients report
having a co-occurring diagnosis of depression and 47.9 percent
report having a co-occurring diagnosis of asthma; and
WHEREAS, Adults and children with eczema also frequently
exhibit comorbidities like asthma, allergic rhinitis, food
allergies, ADHD, bacterial and viral infections, and
hypertension; and

SR1369 - 2 - LRB100 19627 ALS 34900 r
WHEREAS, Eczema's disease burden also includes anxiety,
stress on social and intimate relationships, increased
suicidal ideation, delayed developmental achievement, reduced
self-esteem, restrictions on diet and exercise, extensive
caregiver burdens, and challenges with medication adherence;
and
WHEREAS, Eczema results in missed days of school and work
for patients and caregivers, disability, and reduced ability
within a patient's chosen profession, unemployment and
underemployment, and other opportunity costs; and
WHEREAS, The direct medical costs of the three most common
types of eczema exceed $2.17 billion, and the indirect medical
costs exceed $927 million; and
WHEREAS, Two-thirds of eczema patients report experiencing
significant access barriers, including high out-of-pocket
costs and insurance requirements that delay patients' access to
medications; and
WHEREAS, There is no cure for eczema, but emerging
technologies and medications promise a much brighter future for
eczema patients; therefore, be it
RESOLVED, BY THE SENATE OF THE ONE HUNDREDTH GENERAL

SR1369 - 3 - LRB100 19627 ALS 34900 r
ASSEMBLY OF THE STATE OF ILLINOIS, that the month of October
2018 is designated as Eczema Awareness Month and residents are
encourage to show support for Eczema Awareness.